Ministry of Public Health and GSK Push Medical Investment Hub to Attract Over 1.5 Billion Baht in Investment, Boosting Thailand as a Hub for Research and Vaccines
Published
The Ministry of Public Health of Thailand and GSK are jointly driving the Medical Investment Hub project, which aims to attract medical investment into Thailand. The project has an estimated investment value of approximately 1.5 billion baht.
The Medical Investment Hub project seeks to elevate Thailand into a center for medical research and vaccine production. This collaboration enables the public and private sectors to work together more closely, both in drug and vaccine development and in building confidence among foreign investors.
Investment in vaccine research and production is considered important for the country's public health system, as it helps Thailand rely more on itself for medicines and vaccines. It also helps create jobs for medical personnel and scientists in the country.
Implementing this project will help Thailand play a greater role in the medical industry of the Southeast Asian region. Stakeholders expect that cooperation between government agencies and international pharmaceutical companies will help drive new medical innovations in the future.
Sources: thairath.co.th
More Thailand news
- Finalists Announced for “Best Digital News 2026” with 160 Works from 16 News Outlets
- Song and Bow Aim to Win the 2027 Thailand Volleyball League Championship
- Martian Dust Clings to Spacesuits, Potentially Posing Future Health Risks for Astronauts
- Thai national leads VC fund in Silicon Valley, opening doors for investors to access world-class Deep Tech
- Cabinet Approves Adjustment to Import Duty Criteria for Online Goods to Support Thai SMEs
- Prime Minister Opens Diwali 2026 Festival, Highlighting Thai-Indian Friendship and Promoting Thailand as a Global Cultural Tourism Destination
- Thai Political News for November 10, 2569
- AI and Open Data May Help Scrutinise Thailand's State Budget